Materials

Category VIEW ALL

chevron_right

Software & IT (8)

chevron_right

Engineering & Physical Sciences (9)

chevron_right

chevron_right

Life Sciences (210)

Agriculture (5)

Biochemicals & Small Molecules (23)

Biologics (25)

Consumer Health (4)

Dental (2)

Diagnostics (25)

Digital Health (0)

Drug Delivery Systems (6)

Genetic Engineering (7)

Imaging (7)

Materials (67)

Cell Lines (28)

Mouse Models (34)

Vectors (3)

Medical devices (5)

Medical Questionnaires (1)

MRI & Spectroscopy (0)

Neuroscience (8)

Platform Technology (16)

Rare Diseases (3)

Research tools (33)

Drug Development (5)

Gene Editing (4)

Oncology (13)

Reagents (2)

Sequencing (3)

Tissue Engineering (4)

Various (2)

Therapeutics (85)

Antibacterial (5)

Antiparasitic (2)

Autoimmune Disease (7)

Cardiovascular Disease (5)

Chronic Pain (4)

Dental (2)

Diabetes (2)

Epigenetics (1)

Gene Therapy (3)

Immunology (1)

Immunotherapy (2)

Infectious Disease (11)

Inflammatory Disease (8)

Liver Disease (2)

Kidney Disease (4)

Men's Health (1)

Metabolic Diseases (6)

Neurodegenerative Diseases (9)

Oncology (29)

Orthopedics (2)

Women's Health (2)

Wound Healing (1)

Regenerative Medicine (1)

Vaccines (0)

Veterinary Health (2)

chevron_right

chevron_right

Creative Works (12)

chevron_right

Express Licenses (12)

Vector-Based Replicons for Enhanced Genetic Payload Delivery and Vaccine Formulations

Technology No. TEN01-03

Murine Cell Line - Kras G12D/p53 -/-

Technology No. WON02-10

Murine Cell Line - Kras G12D, Lkb1 -/-, p53 -/-

Technology No. WON02-09

Murine Cell Line - Kras G12D/Lkb1 -/-

Technology No. WON02-08

FINO2 Compound for Ferroptosis (150 mg)

Technology No. WOE01-04

Anti-human/mouse PrP antibody (TW1 clone) hybridoma cells

Technology No. WIS02-28

OT-II LAG-3-/- mouse

Technology No. WAN05-21

OT-I LAG-3-/- mouse

Technology No. WAN05-20

RAGE conditional knockout transgenic mice (Columbia)

Technology No. SCH08-11

AGER Conditional Knockout Transgenic Mice (Columbia)

Technology No. SCH08-10

Diaph1 conditional knockout transgenic mice (Columbia)

Technology No. SCH08-09

Addback clonal pair of Kras G12D/p53/Keap1 Murine Cell Line (HHMI/MIT)

Technology No. PAP02-10

Kras G12D/p53/Keap1 Murine Cell Line (HHMI/MIT)

Technology No. PAP02-09

Engineered murine fallopian tube epithial cell line that contains rp53 -/-; Brca1 -/-; MycOE

Technology No. NEE02-11

Engineered murine fallopian tube epithial cell line that contains rp53 -/-; Ccne1OE; MycOE

Technology No. NEE02-10

B6.Cg-Ptprca Cx3cr1tm1Litt/LittJ (Jax No. 008451) Transgenic mice (HHMI)

Technology No. LIT01-61

GHOST (3) CXCR4+CCR5+ cell line (NIH AIDS Reagent Program Catalog Number: 3942) (HHMI)

Technology No. LIT01-60

Mouse IgG1 monoclonal antibodies directed to human ROR gamma (DNA binding domain) produced by clone 4F3-3C8-2B7 (HHMI)

Technology No. LIT01-59

B6.129P2-Runx1tm1Tani/J transgenic mice (HHMI) (Jax No. 008772)

Technology No. LIT01-58

C57BL/6-Tg(Tcra,Tcrb)2Litt/J transgenic mice (HHMI) (Jax. No. 027230)

Technology No. LIT01-57

DC-SIGN transgenic mice (HHMI)

Technology No. LIT01-53

B6.FVB-Tg(Rorc-cre)1Litt/J transgenic mice (Jax. No 022791) (HHMI)

Technology No. LIT01-41

C57BL/6-Tg(Cd8a-cre)1ltan/J transgenic mice (Jax No. 008766) (HHMI)

Technology No. LIT01-38

Humanized mouse line expressing the human WT or CX3CR1I249/ M280 polymorphic variant (HHMI/USTA)

Technology No. LIT01-29

C.129P2-Cxcr6tm1Litt/J transgenic mice (HHMI) (Jax No. 005700)

Technology No. LIT01-10

B6.129P2-Cxcr4tm2Yzo/J transgenic mice (HHMI) (Jax No. 008767)

Technology No. LIT01-09

Pla2g12b floxed mice

Technology No. HUS02-17

Technology No. HUS02-16

Leydig-cell specific MTP deficient mice

Technology No. HUS02-15

Placenta-specific MTP deficient mice

Technology No. HUS02-14

Zfp961 floxed mice

Technology No. HUS02-13

Casz1 floxed mice

Technology No. HUS02-12

Mouse Leydig MA10 cell line deficient in SREPB2 (ATCC parent)

Technology No. HUS02-11

Mouse Leydig MA10 cell line deficient in MTTP (ATCC parent)

Technology No. HUS02-10

Apolipoprotein B deficient hepatoma cell line (VA)

Technology No. HUS02-07

human hepatoma cell line deficient in microsomal triglyceride transfer protein (MTTP) (VA)

Technology No. HUS02-06

SERPINB2 deficient cell lines for enhanced AdV manufacturing purposes

Technology No. DIT01-03

Human Colonic Epithelial Cell (hCEC) Line (UTSW)-Chr X (not cloned)

Technology No. DAV06-26

Human Colonic Epithelial Cell (hCEC) Line (UTSW)-Chr 13+21 (not cloned)

Technology No. DAV06-25

Human Colonic Epithelial Cell (hCEC) Line (UTSW)-Chr 18 (not cloned)

Technology No. DAV06-24

Human Colonic Epithelial Cell (hCEC) Line (UTSW)-Chr 12 (not cloned)

Technology No. DAV06-23

Human Colonic Epithelial Cell (hCEC) Line (UTSW)-Chr 9 (not cloned)

Technology No. DAV06-22

Human Colonic Epithelial Cell (hCEC) Line (UTSW)-Chr 8 (not cloned)

Technology No. DAV06-21

Human Colonic Epithelial Cell (hCEC) Line (UTSW)-Chr 6 (not cloned)

Technology No. DAV06-20

Human Colonic Epithelial Cell (hCEC) Line (UTSW)-Chr 7 gain (x2)

Technology No. DAV06-19

Human Colonic Epithelial Cell (hCEC) Line (UTSW)-Chr 18q loss (x2)

Technology No. DAV06-17

Human Colonic Epithelial Cell (hCEC) Line (UTSW)-control Ctr sgNC (x2)

Technology No. DAV06-14

LS513 colorectal cancer (ATCC parent) - Chr 7-trisomic/7-disomic cell lines

Technology No. DAV06-06

LoVo Colorectal Cancer (ATCC parent) - Chr 5-trisomic/5-disomic cell lines

Technology No. DAV06-18

LoVo Colorectal Cancer (ATCC parent) - Chr 7-trisomic/7-disomic cell lines

Technology No. DAV06-05

Reh Cell line overexpressing NSD2 E1099K

Technology No. CAR01-04

UBA1 Knockout THP-1 Cell Line for the study of VEXAS (ATCC parent)

Technology No. BEC01-03

Axsl1 fl/fl:Tet2 fl/fl Conditional Knockout Mice

Technology No. AIF01-23

Susd6 fl/fl Conditional Knockout Mice

Technology No. AIF01-22

Clpb fl/fl Conditional Knockout Mice

Technology No. AIF01-21

C57BL/6 (Rosa-rtTA shTet3)

Technology No. AIF01-19

C57BL/6 (Rosa-rtTA shTet2)

Technology No. AIF01-18

C57BL/6 (Rosa-rtTA shTet1)

Technology No. AIF01-17

Conditional AsxL1 Knock-out Mouse Model (Jax No. 025665)(MSKCC)

Technology No. AIF01-16

CX3CR-1GFP transgenic mice (B6.129P2(Cg)-Cx3cr1tm1Litt/J; Jax stock number: 005582)

Technology No. LIT01-37

Optimized Retron Editors for Enhanced Genome Engineering in Mammalian Cells

Technology No. POI01-07

miRNA-Mediated Transgene Expression System for Improved Gene Therapies and Research Reagent Applications

Technology No. TEN01-04

CD11c-DTR Transgenic Mice (B6.FVB-1700016L21RikTg [Itgax-DTR/EGFP] 57Lan/J; Jax stock number: 004509 )

Technology No. LIT01-08

TET2 Conditional Knockout Transgenic Mice

Technology No. AIF01-14

Human Immunodeficiency Virus 1 (HIV-1) NL4-3 ΔEnv Vpr Luciferase Reporter Vector (pNL4-3.Luc.R-E-)

Technology No. LAN02-04

Nano Zeolite-Y: A Novel and Cost-Effective Antibacterial Composition

Technology No. ANI01-01

PKP2cKO Transgenic Mouse Model

Technology No. DEL05-01

Transgenic Mouse Model Expressing C217G Uromodulin

Technology No. WU01-01